Correction: Combined antitumor activity of [177Lu]Lu-FAPI-2286 and pazopanib in a sarcoma model: a preclinical theranostic study targeting fibroblast activation protein.
Saved in:
| Title: | Correction: Combined antitumor activity of [177Lu]Lu-FAPI-2286 and pazopanib in a sarcoma model: a preclinical theranostic study targeting fibroblast activation protein. |
|---|---|
| Authors: | Tseng, Jing-Ren1,2,3 (AUTHOR) drtsengjr@gmail.com, Hsu, Cheng-Lung4 (AUTHOR) hsu2221@adm.cgmh.org.tw, Hsieh, Hsin-Hua5 (AUTHOR) alexa851024@gmail.com, Ho, Kung-Chu3,6 (AUTHOR) b8301068@gmail.com, Wu, Chun-Yi5 (AUTHOR) chunyiwu@nycu.edu.tw, Lin, Ko-Han7,8 (AUTHOR) khlin1979@gmail.com, Chung, Yi-Hsiu9 (AUTHOR) stella720905@gmail.com, Weng, Chi-Chang6,9 (AUTHOR) ccweng@mail.cgu.edu.tw |
| Source: | EJNMMI Research. 4/28/2026, Vol. 16 Issue 1, p1-1. 1p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2191219X |
|---|---|
| DOI: | 10.1186/s13550-026-01443-7 |
